Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.71 |
| ▸ | CA9 | Q16790 | 6/20 | 0.59 |
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA1 | P00915 | 5/20 | 0.59 |
| ▸ | CA2 | P00918 | 5/20 | 0.59 |
| ▸ | CA7 | P43166 | 5/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | HMGCR | P04035 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29457562 | 1.00 | HSP90AB1 (0.71) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL9602694 | 0.84 | ALDH1A1 (0.63) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL481085 | 0.83 | HSP90AB1 (1.00) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL29457585 | 0.83 | HSP90AB1 (1.00) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL4706474 | 0.83 | HSP90AB1 (1.00) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL7769565 | 0.83 | CA12 (0.61) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL27963603 | 0.82 | HSP90AB1 (0.70) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL1305878 | 0.82 | CSNK2A1 (0.62) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL29368656 | 0.82 | CSNK2A1 (0.62) | HSP90AB1CA9CA12CA1CA2 | |
| SCHEMBL28049448 | 0.82 | HSP90AB1 (0.96) | HSP90AB1CA9CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11673997-B2 | Work time to walk-on time ratio by adding a phenolic catalyst to polyaspartic flooring formulations | COVESTRO LLC (US) | 2023-06-13 | — | — | US | claimed |
| EP-4004076-A1 | IMPROVED WORK TIME TO WALK-ON TIME RATIO BY ADDING A PHENOLIC CATALYST TO POLYASPARTIC FLOORING FORMULATIONS | Covestro LLC (US) | 2022-06-01 | — | — | EP | claimed |
| CN-114144454-A | Improved operating time to open-run time ratio by adding phenolic catalysts to polyaspartic flooring formulations | 科思创有限公司 | 2022-03-04 | — | — | CN | claimed |
| WO-2021021801-A1 | IMPROVED WORK TIME TO WALK-ON TIME RATIO BY ADDING A PHENOLIC CATALYST TO POLYASPARTIC FLOORING FORMULATIONS | COVESTRO LLC (US) | 2021-02-04 | — | — | WO | claimed |
| EP-3404026-A1 | PYRIMIDO-ISOQUINOLIN-QUINONE DERIVATIVE COMPOUNDS, AND PHARMACEUTICALLY ACCEPTABLE SALTS, ISOMERS AND TAUTOMERS THEREOF; PHARMACEUTICAL COMPOSITION; PREPARATION METHOD; AND USE THEREOF IN THE TREATMENT OF DISEASES CAUSED BY BACTERIA AND MULTIDRUG-RESISTANT BACTERIA | Universidad De Chile (CL) | 2018-11-21 | — | — | EP | claimed |
| CN-106854143-A | A kind of synthetic method of hydroquinone derivative | 湖南华腾制药有限公司 | 2017-06-16 | — | — | CN | claimed |
| EP-2374853-A1 | Cyanate ester-based pressure sensitive adhesive | CORNERSTONE RESEARCH GROUP, INC. (US) | 2011-10-12 | — | — | EP | claimed |
| US-20100168279-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | HENKEL AG & CO. KGAA (DE) | 2010-07-01 | — | — | US | claimed |
| US-20100137554-A1 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. | 2010-06-03 | — | — | US | claimed |
| EP-1979397-A4 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RES GROUP INC (US) | 2009-04-08 | — | — | EP | claimed |
| US-20080255228-A1 | Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| EP-1979397-A2 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2008-10-15 | — | — | EP | claimed |
| US-7427690-B2 | Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration | BIODERM RESEARCH (US) | 2008-09-23 | — | — | US | claimed |
| WO-2008051241-A2 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2008-05-02 | — | — | WO | claimed |
| WO-2007114822-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2007-10-11 | — | — | WO | claimed |
| US-20070099886-A1 | Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration | BIODERM RESEARCH (US) | 2007-05-03 | — | — | US | claimed |
| CN-1882602-A | Modulation and degradation of hyaluronan synthesis in the treatment of disease | MEDITECH RES LTD (AU) | 2006-12-20 | — | — | CN | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| US-20050271608-A1 | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives | GUPTA SHYAM K | 2005-12-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | PSMB1, PLOD3, CUTA | HSP90AB1 677/4885CA9 4380/4885CA12 4776/4885 |
| US-20080255228-A1 | Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles | PROC, COL1A1, CUTA | HSP90AB1 1306/4885CA9 1095/4885CA12 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.